4.14
Lixte Biotechnology Holdings Inc (LIXT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
9.60%
0.7748
|
0.7069 | 0.6135 | 0.9833 | 1.0092 |
Interest Income/Expense |
42.26%
0.00181
|
0.00314 | 0.00443 | 0.00105 | 0.00415 |
Operating Income/Loss |
9.60%
-0.7748
|
-0.7069 | -0.6135 | -0.9833 | -1.0092 |
Income/Loss From Continuing Operations Before Tax |
9.32%
-0.7757
|
-0.7096 | -0.6177 | -0.986 | -1.0109 |
Income/Loss From Continuing Operations After Tax |
9.32%
-0.7757
|
-0.7096 | -0.6177 | -0.986 | -1.0109 |
|
9.32%
-0.7757
|
-0.7096 | -0.6177 | -0.986 | -1.0109 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
10.08%
2.7205
|
2.4715 | - | 2.2493 | 2.2493 |
Diluted Average Shares |
10.08%
2.7205
|
2.4715 | - | 2.2493 | 2.2493 |
Basic Earnings Per Share |
0.00%
-0.29
|
-0.29 | -0.27 | -0.44 | -0.45 |
Diluted Earnings Per Share |
0.00%
-0.29
|
-0.29 | -0.27 | -0.44 | -0.45 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):